Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
TAMPA, Fla. (WFLA) — Medical specialists advised Information Channel 8 that abdomen most cancers is declining in sufferers older than 60, however is...
Komal Jhaveri, MD, FACP, part head, Endocrine Remedy Analysis Program, medical director, Early Drug Growth Service, Patricia and James Cayne Chair for Junior...
